We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IRON market cap is 1.86B. The company's latest EPS is USD -2.5684 and P/E is -4.93.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.96M | -29.71M | -31.46M | -30.85M | -32.86M |
| Net Income | -14.12M | -23.58M | -26.95M | -26.35M | -26.6M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -817k | -69M | -47.48M | -91.13M |
| Net Income | -812k | -71.87M | -46.83M | -76.43M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 376.5M | 368M | 354.18M | 510.22M | 495.15M |
| Total Liabilities | 17.52M | 22.88M | 16.11M | 21.39M | 27.19M |
| Total Equity | 358.97M | 345.12M | 338.07M | 488.83M | 467.96M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 122.09M | 140.44M | 200.21M | 368M |
| Total Liabilities | 4.82M | 15.6M | 23.61M | 22.88M |
| Total Equity | 5M | 124.84M | 176.6M | 345.12M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -55.67M | -73.46M | -33.6M | -48.99M | -66.35M |
| Investing | -86k | -89k | -67k | -219.82M | -290.91M |
| Financing | 231.62M | 239.38M | 15.9M | 189.09M | 189.52M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -416k | -59.7M | -42.25M | -73.46M |
| Investing | -120.75M | 344k | -151k | -89k |
| Financing | 122.38M | 191.48M | 148.98M | 239.38M |
| Market Cap | 1.86B |
| Price to Earnings Ratio | -4.93 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.05 |
| Price to Book Ratio | 1.09 |
| Dividend Yield | - |
| Shares Outstanding | 29.76M |
| Average Volume (1 week) | 112.73k |
| Average Volume (1 Month) | 236.51k |
| 52 Week Change | 9.12% |
| 52 Week High | 77.60 |
| 52 Week Low | 25.60 |
| Spread (Intraday) | 43.95 (63.94%) |
| Company Name | Disc Medicine Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.discmedicine.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
